# AEHR — Aehr Test Systems · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** AEHR  
**Sources:** 20  
**Published:** 2026-10-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-aehr-aehr-test-systems-catalysts-narrative-risks-5871

---

## Recent catalysts (July–October 2026)

**Q4 FY2026 earnings release (reported July 14, 2026)** — This is the most material recent catalyst. Despite a weaker full year, the quarter showed a sharp inflection:
- Q4 FY2026 revenue of $18.8 million, +34% year-over-year, and a return to profitability (non-GAAP net income of $3.6 million / $0.11 per share, vs. a $0.2 million loss a year earlier; non-GAAP gross margin of 45%) [[1]](https://finance.yahoo.com/markets/stocks/articles/aehr-test-systems-aehr-q4-050023797.html).
- Record Q4 bookings of $60.7 million (up more than 500% year-over-year) and a backlog of $80.6 million at quarter-end (effective backlog ~$100.6 million post quarter-end) [[1]](https://finance.yahoo.com/markets/stocks/articles/aehr-test-systems-aehr-q4-050023797.html), [[17]](https://www.ainvest.com/stocks/NASDAQ-AEHR/financials/earnings/).
- A very strong forward guide: FY2027 revenue of $130–$150 million (roughly 160%–200% growth) and 18%–22% pre-tax non-GAAP net-income margin, plus $116.5 million in cash [[1]](https://finance.yahoo.com/markets/stocks/articles/aehr-test-systems-aehr-q4-050023797.html).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-aehr-aehr-test-systems-catalysts-narrative-risks-5871 (free to sign up)._
